|
To: Superintendents, Charter School & Private School Leaders, Principals, Reopening Advisors, and School Nurses
From: Kati Moseley, Ready Schools, Safe Learners Resiliency Manager
Subject: Updates on CDC guidance and Expansion of COVID-19 Booster Approved for Oregonians Ages 12–15
Dear Colleagues,
Throughout this academic year, with each challenge that COVID-19 has brought to Oregon schools, educators, families, and communities have demonstrated their strength. Doors to Oregon schools have remained open with students learning in-person. Thank you for your tireless efforts.
This message contains clarifying guidance for Oregon K–12 schools from the Center for Disease Control and Prevention (CDC) and Oregon Health Authority (OHA) related to:
-
What it means to be “Up to date” for COVID-19 vaccinations
-
Shortened quarantine and isolation guidance
-
Test to stay updates including launch of the home testing option within the test to stay protocol
-
Expansion of Pfizer-BioNTech booster dose eligibility to 12 to 15-year-olds
"Up to Date" Status Definition of COVID-19 Vaccination
CDC recommends that individuals remain up to date with their vaccines, which includes additional doses for those who are immunocompromised or booster doses at regular time points. Within the K–12 setting, those who are up to date with their COVID-19 vaccination include:
-
Individuals 18 or older who have received all recommended vaccine doses, including boosters and additional primary shots for some immunocompromised people.
-
Youth 5–17 years who have completed the primary series of COVID-19 vaccines.
Shortened Quarantine and Isolation Periods for K–12 Settings
CDC has reduced the recommended time for quarantine and isolation for the general public to five days.
Quarantine: Students, teachers, and staff who come into close contact with someone with COVID-19 and are up to date with their COVID-19 vaccination as defined by CDC and individuals who had confirmed COVID-19 (tested positive using a COVID-19 viral test) within the last 90 days do not need to quarantine. These individuals should:
-
Wear a well-fitting mask around others for 10 days from the date of their last close contact with someone with COVID-19 (the date of last close contact is considered day 0) and watch for symptoms of COVID-19.
-
Get tested at least 5 days after having close contact with someone with COVID-19. If they test positive or develop COVID-19 symptoms, they should follow recommendations for isolation.
Individuals who come into close contact with someone with COVID-19 and are not up to date with their COVID-19 vaccination defined by CDC as:
-
Ages 18 years or older and completed the primary series of a two dose recommended vaccine more than 5 months ago but have not received a recommended booster shot.
-
Those who have received the single-dose Johnson & Johnson vaccine (completing the primary series) over 2 months ago and have not received a recommended booster shot.
-
Those who are not fully vaccinated or have not completed a primary vaccine series.
These individuals should quarantine as follows:
-
Quarantine for at least 5 days after their last close contact with someone with COVID-19. Individuals in quarantine should not go to school or school events in-person during their quarantine period unless they are participating in a school sponsored test-to-stay protocol.
-
Wear a well-fitting mask around others for 10 days from the date of their last close contact with someone with COVID-19 (the date of last close contact is considered day 0) and watch for symptoms of COVID-19.
-
Get tested at least 5 days after having close contact with someone with COVID-19. If they test positive or develop COVID-19 symptoms, they should follow recommendations for isolation.
-
If unable to wear a mask, an individual should complete a 10-day quarantine.
-
If an individual is unable to quarantine, they should wear a well-fitting mask around others at home and in public for 10 days.
-
Individuals can end isolation after 5 full days since symptom onset if they are fever-free for 24 hours without the use of fever-reducing medication and their other symptoms have improved.
-
Day 0 is the day symptoms began or the day the person took a test that had a positive result. Day 1 is the day after symptoms began or, if a person does not have symptoms, the day after the person tested positive (use the date the test was collected).
-
If they continue to have fever or their other symptoms have not improved after 5 days of isolation, they should stay in isolation until they are fever-free for 24 hours without the use of fever-reducing medication and their other symptoms have improved.
-
Individuals should continue to wear a well-fitting mask around others at home and in public places for an additional 5 days (day 6 through day 10) after the end of their 5-day isolation.
Test to Stay Updates and Launch of At-Home Testing Option
Following the CDC recommendation of a 5-day quarantine period, the test to stay protocol’s eligibility and testing timeframes have been updated to align. OHA has provided details on these updates here.
For test to stay using at-home tests, schools will distribute a single test kit containing two tests to exposed students and staff. Testing is then performed at home and students who continue to test negative may be allowed to continue with in-person instruction in a modified quarantine. For children under age 15, the parent/guardian must perform the testing. The updated K–12 testing guidance is available here.
At-home or self-testing does not have to be reported through the K–12 reporting portal. Families participating in test to stay using at-home testing may be asked to sign a results attestation form, and schools are not required to verify test results. At-home tests may only be used to facilitate test to stay; they may not be used for student screening.
Schools may offer both at-school and at-home test to stay options and may enroll in self-testing here. The ordering form for the iHealth self-tests for school districts is available here.
An Expansion of the Pfizer-BioNTech Booster Dose Eligibility to Anyone 12 Years of Age or Older
Following updated guidance from the CDC, and review by the Western States Scientific Safety Review Workgroup, Governor Kate Brown announced late last week that children age 12 years and older across Oregon are now eligible for the Pfizer-BioNTech vaccine booster dose. Additionally, the CDC has shortened the time between the completion of the primary series of the Pfizer-BioNTech and Moderna COVID-19 vaccines and a booster dose to at least 5 months, and to allow for a third primary dose for certain immunocompromised children 5 through 11 years of age. OHA is informing health care providers that booster shots for newly eligible individuals can begin in Oregon January 7, 2022.
Guidance issued this week reminds us of the variety of tools and resources ready to help us deal with these difficult challenges together.
-
Getting vaccinated can protect students’ access to in-person learning, sports and extracurricular activities. Oregon’s Ready Schools, Safe Learners Resiliency Framework and CDC guidance states that people who are up to date with their COVID-19 vaccination and do not have COVID-19 symptoms do not need to quarantine after an exposure to someone with COVID-19.
-
Implementing layered health and safety measures to protect students, staff, and families and support in-person learning. This includes symptom screening and staying home when you have signs of infectious illness, indoor masking, physical distancing, ventilation, handwashing, on-site rapid testing, isolation and quarantine, cohorting, etc.
-
Our close partnership with local and state public health professionals helps us to monitor community transmission, vaccination coverage, screening testing, and occurrence of outbreaks.
ODE and OHA will be working hard over the next several weeks to revise our materials to reflect the updated guidance we have received. We will inform you as soon as those materials are available. As always, if you have any questions about this update or other concerns, please contact the ODE COVID-19 inbox at ODECOVID19@ode.state.or.us. Thank you!
|
|
|
|
|